ARCHIVES

Centers, Groups, Others May Land in DeVita’s Office; Hammer Offers Deal congress Can’t Refuse

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

ASCO Special Awards Honor Oncology Leaders.

April 2, 2010

Blacks Less Likely To Receive Standard Radiation Therapy

October 31, 2008

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005